Biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents for primary percutaneous coronary revascularisation of acute myocardial infarction

EuroIntervention 2016;12:e1343-e1354 published online ahead of print December 2015 published online e-edition December 2016. DOI: 10.4244/EIJY15M12_09

Thomas Pilgrim
Thomas Pilgrim1*, MD; Raffaele Piccolo1, MD; Dik Heg2, PhD; Marco Roffi3, MD; David Tüller4, MD; André Vuilliomenet5, MD; Olivier Muller6, MD; Stéphane Cook7, MD; Daniel Weilenmann8, MD; Christoph Kaiser9, MD; Peiman Jamshidi10, MD; Ahmed A. Khattab1, MD; Masanori Taniwaki1, MD; Fabio Rigamonti3, MD; Fabian Nietlispach1, MD; Stefan Blöchlinger1, MD; Peter Wenaweser1, MD; Peter Jüni11,12, MD; Stephan Windecker1, MD
1. Department of Cardiology, Swiss Cardiovascular Center, University Hospital, Bern, Switzerland; 2. Institute of Social and Preventive Medicine and Clinical Trials Unit, Bern University Hospital, Bern, Switzerland; 3. Department of Cardiology, University

Aims: Our aim was to compare the safety and efficacy of a novel, ultrathin strut, biodegradable polymer sirolimus-eluting stent (BP-SES) with a thin strut, durable polymer everolimus-elut

Sign in to read and download the full article

Forgot your password?

No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from

acute myocardial infarcationbiodegradable polymerdurable polymereverolimus-eluting stentssirolimus-eluting stents
Coronary interventionsSTEMIStents and scaffoldsTools, devices and techniquesTools, devices and techniques
Read next article
IVUS-guided treatment strategies for definite late and very late stent thrombosis

Latest news